1 Min Read
March 19 (Reuters) - Viveve Medical Inc:
* VIVEVE ANNOUNCES FDA APPROVAL OF IDE TO CONDUCT VIVEVE II CLINICAL STUDY
* VIVEVE MEDICAL INC - VIVEVE II CLINICAL TRIAL EXPECTED TO BEGIN IN Q2 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.